Ignite Creation Date:
2024-05-06 @ 3:03 PM
Last Modification Date:
2024-10-26 @ 1:41 PM
Study NCT ID:
NCT04501120
Status:
RECRUITING
Last Update Posted:
2024-05-29
First Post:
2020-08-03
Brief Title:
Study of APG2575 Single Agent and Combination With Therapy in Patients RelapsedRefractory AML
Sponsor:
Ascentage Pharma Group Inc
Organization:
Ascentage Pharma Group Inc